Macrolide antibiotics are a particular type of antibiotic used to treat, and sometimes prevent, a wide variety of bacterial infections. Macrolide antibiotics stop bacteria multiplying by preventing them from being able to produce proteins that are essential for their growth. The bacteria eventually die or are killed by your immune system.
Macrolide antibiotics are used to treat infections caused by Gram-positive bacteria (e.g., Streptococcus pneumoniae) and limited Gram-negative bacteria (e.g., Bordetella pertussis, Haemophilus influenzae), and some respiratory tract and soft-tissue infections. The antimicrobial spectrum of macrolides is slightly wider than that of penicillin, and, therefore, macrolides are a common substitute for patients with a penicillin allergy.

The global Macrolide Antibiotics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Macrolide Antibiotics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Macrolide Antibiotics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Macrolide Antibiotics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Macrolide Antibiotics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Merck
Pfizer
Teva Pharmaceutical Industries
Fresenius Kabi
Sandoz International
Macrolide Pharmaceuticals
Neo Química
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Azithromycin
Clarithromycin
Erythromycin
Fidaxomicin
Telithromycin

Segment by Application
Hospitals
Dermatology Clinics
Pharmaceutical Companies